Virology. Capitalizing on HIV's talents for gene therapy

The emerging understanding of HIV's journey from the cell membrane to the nucleus may help researchers design better vectors for gene therapy for a variety of diseases. Researchers are using HIV itself as a gene-therapy vector, thereby capitalizing on its ability to infect nondividing cells.